Preoperative chemotherapy in stage III non-small cell lung cancer: Long- term outcome

Lung Cancer

Volumn 26, Issue 1, 1999, Pages 3-6

  Gandara, David R ^a   Leigh, Bryan ^a   Vallieres, Eric ^b   Albain, Kathy S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER STAGING; CANCER SURGERY; HEALTH CARE QUALITY; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; HUMANS; LONGITUDINAL STUDIES; LUNG NEOPLASMS; NEOPLASM STAGING; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0033214378     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(99)00056-2     Document Type: Article

References (16)

1. Einhorn L.H. Neoadjuvant and adjuvant trials in non-small cell lung cancer. Ann Thorac Surg. 65:1998;208-211.
2. Edelman J.M., Gandara D.R., Roach M., Benfield J. Multi-modality therapy in stage III non-small cell lung cancer. Ann Thorac Surg. 61:1996;1564-1572.
3. Albain K.S. Induction chemotherapy with or without radiotherapy followed by surgery in non-small cell lung cancer. Van Houtte P., Klastersky J., Roscman P. Progress and Perspectives in the Treatment of Lung Cancer. 1999;53-72 Springer-Verlag.
4. Sugarbaker D.J., Herndon J., Kohman L.J., Krasna M.J., Green M.R. Results of Cancer and Leukemia Group B Protocol 8935. A multi-institutional phase II tri-modality trial for stage IIIA (N2) non-small cell lung cancer. J Thorac Cardiovasc Surg. 109:1995;473-485.
5. Roth J., Fossella F., Komaki R. et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III non-small cell lung cancer. J Natl Cancer Inst. 86:1994;673-680.
6. Rosell R., Gomez-Codina J., Camps C. et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med. 330:1994;153-158.
7. Pass H.I., Pogrebniak H.W., Steinberg S.M., Mulshine J., Minna J. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg. 53:1992;992-998.
8. Albain K.S., Rusch V.W., Crowley J.J. et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group Phase II Study 8805. J Clin Oncol. 13:1995;1880-1892.
9. Martini N., Kris M.G., Flehinger B.J. et al. Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg. 55:1993;1365-1374.
10. Burkes R.I., Shepherd F.A., Ginsberg R.J. et al. Induction chemotherapy with MVP in patients with stage IIIA (N2) unresectable non-small cell lung cancer: the Toronto experience. Proceedings of ASCO. 13:1994;327.
11. Eberhardt W., Wilke H., Stamatis G. et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer: mature results of a phase II trial. J Clin Oncol. 16:1998;622-634.
12. Splinter TAW, Kirkpatrick A, Darwish S, van Meebeeck J for the EORTC, GOIRC and VKSL. Randomized trial of surgery versus radiotherpay after a response to induction chemotherapry. Intergroup Study 08941. Lung Cancer 1997;18(Suppl 1):62-63.
13. Albain K.S., Rusch V., Crowley J., Rict T., Turrisi A., Weick J., Lonchyna V., Preseant C., McKenna R., Gandara D., Fosmire H., Taylor S., Staza K., Beasley K., Livingston R. Long-term survival after concurrent cistplatin/etoposide plus chest RT followed by surgery in bulky statges IIIA (N2) and IIIB NSCLC: 6-year outcomes from SWOG Study 8805. Proc Am Soc Clin Oncol. 18:1999;467a.
14. Fleck J., Camargo J., Godoy D. et al. Chemoradiation therapy versus chemotherapy alone as a neo-adjuvant treatment for stage III non-small cell lung cancer. Preliminary results of a phase III randomized trial (Abstract). Proc Am Soc Clin Oncol. 12:1993;333.
15. Perry M.C., Deslauriers J., Albain K.S. et al. Induction treatment for resectable non-small cell lung cancer: a consensus report. Lung Cancer. 17(Suppl 1):1997;15-18.
16. Sugarbaker D.J., Herndon J., Decamp M.M., Jaklitsch M.T., Richards W.G., Kumar P., Green M.R. N2 Status at Resection Predicts Long-term Outcome following Induction Therapy for Stage IIIA Non-small Cell Lung Cancer: CALGB 8935. Proc Am Soc Clin Oncol. 17:1998;452a.